Summary
Novacyt is a biotechnology company that develops and markets medical cytology solutions. The company offers consumable products and automated instruments. It offers consumable products such as vials, sedimentation system, and novastick solution. Novacyt also provides automated analysis instruments such as NPS 25 and NPS 50. The company offers cytology services, which are used in pathological anatomy for the morphological analysis of cells in order to diagnose or screen for an illness such as cancer. Its cytology solution is also used in medical laboratories for diagnoses of diseases based on the study of organs and tissues on a molecular level. The company markets its products through its network of distributors. Novacyt is headquartered in Velizy-Villacoublay, France.
Novacyt (ALNOV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Novacyt, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Novacyt, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Novacyt, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Novacyt, Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Novacyt, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Novacyt, Medical Equipment, Deal Details 12
Asset Purchase 12
Novacyt Acquires Assets Of Centre de Competences International en Tele-Imagerie 12
Venture Financing 13
Lab21 Raises US$7.7 Million In Venture Financing 13
Novacyt Raises US$2 Million In Venture Financing 14
Private Equity 15
Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 15
Partnerships 16
Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics 16
Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic 17
BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 18
Lab21 Enters Into Co-Development Agreement With Pharma Company 19
LAB21 Enters Into Co-Development Agreement With IVD Company For Aspergillus Molecular Assay 20
BD Diagnostics Enters Into Co-Development Agreement With Lab21 21
Equity Offering 22
Novacyt Raises USD2.2 Million in Private Placement of Shares 22
Novacyt Raises USD2.16 Million in Private Placement of Shares 24
Novacyt to Raise USD3 Million in Private Placement of Shares 25
Debt Offering 26
Novacyt Raises USD3.3 Million in Private Placement of 12.5% Bonds Due 2019 26
Novacyt Raises USD0.27 Million in First Tranche Private Placement of Bonds 27
Asset Transactions 28
Trinity Biotech Acquires Blood Bank Screening Business Of Lab 21 For US$7.5 Million 28
Lab21 Sells South Carolina Operations To Reedy Acquisitions 29
Acquisition 30
Novacyt to Acquire PrimerDesign 30
Novacyt Completes Acquisition of Lab21, Medicine Diagnostics Company 32
Lab21 Acquires Myconostica 34
Lab21 Acquires Microgen Bioproducts 35
Novacyt - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Jan 13, 2016: Novacyt Revenues Full Year 2015 39
Oct 28, 2015: Novacyt Announces 2015 Half Year Results 41
Jul 20, 2015: Strong First-half Revenues Completes €3.5m in Bond Refinancing and Launches a €1.7m private placement 43
Apr 29, 2015: Novacyt Full Year 2014 Results 45
Corporate Communications 48
Jul 02, 2015: Novacyt Strengthens Board 48
Mar 10, 2015: Novacyt Appoints New Group Commercial Director 49
Product News 50
Feb 15, 2016: Novacyt Expands Distribution Presence in Asia Pacific 50
Nov 12, 2015: Novacyt Launch Next Generation NOVAprep Instrumentation in China 51
Mar 04, 2015: Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep in Greater China 52
Feb 25, 2015: Novacyt Receives Approval in China for NOVAPrep 53
Product Approvals 54
Feb 25, 2015: Novacyt Receives Approval in China for NOVAPrep 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Tables
Novacyt, Medical Equipment, Key Facts, 2014 1
Novacyt, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Novacyt, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Novacyt, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Novacyt, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Novacyt, Deals By Market, 2010 to YTD 2016 9
Novacyt, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Novacyt Acquires Assets Of Centre de Competences International en Tele-Imagerie 12
Lab21 Raises US$7.7 Million In Venture Financing 13
Novacyt Raises US$2 Million In Venture Financing 14
Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 15
Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics 16
Lab21 Enters Into Agreement With IntegraGen To Develop Cancer Diagnostic 17
BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 18
Lab21 Enters Into Co-Development Agreement With Pharma Company 19
LAB21 Enters Into Co-Development Agreement With IVD Company For Aspergillus Molecular Assay 20
BD Diagnostics Enters Into Co-Development Agreement With Lab21 21
Novacyt Raises USD2.2 Million in Private Placement of Shares 22
Novacyt Raises USD2.16 Million in Private Placement of Shares 24
Novacyt to Raise USD3 Million in Private Placement of Shares 25
Novacyt Raises USD3.3 Million in Private Placement of 12.5% Bonds Due 2019 26
Novacyt Raises USD0.27 Million in First Tranche Private Placement of Bonds 27
Trinity Biotech Acquires Blood Bank Screening Business Of Lab 21 For US$7.5 Million 28
Lab21 Sells South Carolina Operations To Reedy Acquisitions 29
Novacyt to Acquire PrimerDesign 30
Novacyt Completes Acquisition of Lab21, Medicine Diagnostics Company 32
Lab21 Acquires Myconostica 34
Lab21 Acquires Microgen Bioproducts 35
Novacyt, Key Competitors 36
Novacyt, Key Employees 37
Novacyt, Subsidiaries 38
List of Figures
Novacyt, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Novacyt, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Novacyt, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Novacyt, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Novacyt, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Novacyt, Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Novacyt, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Novacyt, Medical Equipment, Deals by Market, 2010 to YTD 2016 9
